A correction notice related to terlipressin was published on September 1, 2026. The correction applies to the article titled "Terlipressin Therapy for Portal Hyperperfusion Secondary to Portal Vein Size Discrepancy After Pediatric Liver Transplant." It appeared in the journal Pediatric Transplantation.
The correction addresses the original publication describing terlipressin use in a pediatric liver transplant context involving portal vein size discrepancy and portal hyperperfusion. No details of the correction's specific content, such as which data or conclusions were revised, were included in this listing. The entry is indexed under PubMed ID 42746863.
This notice is a bibliographic correction to a previously published paper and does not represent new trial results or new safety findings on terlipressin. Readers interested in the original findings or the nature of the correction should consult the full text through the linked source. As with any published correction, it reflects an update to the scientific record rather than a new independent study.
For general information on terlipressin, including its approved uses and background, readers can consult the compound overview.